Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Atia Medical focuses on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
GondolaBio researches, develops and manufactures pharmaceutical products.
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Epic Bio's strength is a relentless focus on ushering in a new era of gene regulation.
Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
Navigantis empowers physicians to deliver uncompromised neurovascular care by creating a new frontier in surgical robotics.
Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
Erasca is a developer of oncology drugs intended to provide precision oncology options.
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Myra Vision develops a treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
Cormorant Asset Management has invested in 209 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cormorant Asset Management's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Medical Device. The firm invests across 21 different industry categories.
Among tracked funding rounds, Avidity Biosciences received $690.0M in a Post-IPO Equity round. Cormorant Asset Management's total known invested capital is $19.7B.
Cormorant Asset Management's average investment size is $134.8M across its portfolio of 209 companies.
Recent Cormorant Asset Management portfolio additions include Rapport Therapeutics, Ventyx Biosciences, RayzeBio, Avidity Biosciences, Atia Vision. These companies were founded in 2020 or later.